Tags

Type your tag names separated by a space and hit enter

[Propoleum and Peyronie's disease].
Arch Esp Urol. 2003 Sep; 56(7):805-13.AE

Abstract

OBJECTIVES

Peyronie's disease is a plastic penile induration which represents a well-known problem affecting men in their middle age, who suffer penile incurvation during erections, pain and poor consistency at the site of incurvation. There is no satisfactory treatment for this disease. A patient with Peyronie's disease who received propoleum treatment for a giardiasis infection referred spontaneous improvement of this penile incurvation as treatment cycles were repeated. So, we decided to treat a group of patients with this pathologic entity with propoleum to evaluate its efficacy.

METHODS

Initially, 25 patients were studied, only 13 completed the study 6 months later.

VARIABLES

age, penile incurvation, presence or not of pain with erections, detection and measurement (cm) of the fibrous plaque on physical examination and ultrasound, and description of its radiologic characteristics. Propoleum powder (300 mg) was administered for 6 months.

RESULTS

Patient age was predominantly between 51 and 60 years. Upward deviation was the most frequent presentation; it disappeared in 2 patients in the "Improved" group. Most patients had no pain. 3 patients out of 13 had no plaque on examination at the end of treatment. Regarding incurvation 10 patients improved, 2 improved slightly, and only one improved somewhat during the first three months but then after remained the same. Penile x-ray was not useful as a diagnostic test; penile ultrasound was greatly useful.

CONCLUSIONS

Penile incurvation improved in 77% of the patients. Fibrous plaques were reduced more than 0.5 cm on ultrasound (average 0.64 cm).

Links

Publisher Full Text

Authors+Show Affiliations

Lemourt Oliva M
Servicio de Urología, Hospital Docente Quirúrgico Freyre de Andrade, La Habana, Cuba. malem@infomed.sld.cu
Rodríguez Barroso A
No affiliation info available
Puente Guillén M
No affiliation info available
Vega Guerrero C
No affiliation info available
Navarro Cutiño M
No affiliation info available
Pérez Monzón A
No affiliation info available

MeSH

Adjuvants, ImmunologicBiological ProductsHumansMaleMiddle AgedPenile IndurationProspective Studies

Pub Type(s)

English Abstract
Journal Article

Language

spa

PubMed ID

14595885

Citation

Lemourt Oliva, Manuel, et al. "[Propoleum and Peyronie's Disease]." Archivos Espanoles De Urologia, vol. 56, no. 7, 2003, pp. 805-13.
Lemourt Oliva M, Rodríguez Barroso A, Puente Guillén M, et al. [Propoleum and Peyronie's disease]. Arch Esp Urol. 2003;56(7):805-13.
Lemourt Oliva, M., Rodríguez Barroso, A., Puente Guillén, M., Vega Guerrero, C., Navarro Cutiño, M., & Pérez Monzón, A. (2003). [Propoleum and Peyronie's disease]. Archivos Espanoles De Urologia, 56(7), 805-13.
Lemourt Oliva M, et al. [Propoleum and Peyronie's Disease]. Arch Esp Urol. 2003;56(7):805-13. PubMed PMID: 14595885.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Propoleum and Peyronie's disease]. AU - Lemourt Oliva,Manuel, AU - Rodríguez Barroso,Ada, AU - Puente Guillén,Marta, AU - Vega Guerrero,Concepción, AU - Navarro Cutiño,Magdelin, AU - Pérez Monzón,Antonio, PY - 2003/11/5/pubmed PY - 2004/1/7/medline PY - 2003/11/5/entrez SP - 805 EP - 13 JF - Archivos espanoles de urologia JO - Arch Esp Urol VL - 56 IS - 7 N2 - OBJECTIVES: Peyronie's disease is a plastic penile induration which represents a well-known problem affecting men in their middle age, who suffer penile incurvation during erections, pain and poor consistency at the site of incurvation. There is no satisfactory treatment for this disease. A patient with Peyronie's disease who received propoleum treatment for a giardiasis infection referred spontaneous improvement of this penile incurvation as treatment cycles were repeated. So, we decided to treat a group of patients with this pathologic entity with propoleum to evaluate its efficacy. METHODS: Initially, 25 patients were studied, only 13 completed the study 6 months later. VARIABLES: age, penile incurvation, presence or not of pain with erections, detection and measurement (cm) of the fibrous plaque on physical examination and ultrasound, and description of its radiologic characteristics. Propoleum powder (300 mg) was administered for 6 months. RESULTS: Patient age was predominantly between 51 and 60 years. Upward deviation was the most frequent presentation; it disappeared in 2 patients in the "Improved" group. Most patients had no pain. 3 patients out of 13 had no plaque on examination at the end of treatment. Regarding incurvation 10 patients improved, 2 improved slightly, and only one improved somewhat during the first three months but then after remained the same. Penile x-ray was not useful as a diagnostic test; penile ultrasound was greatly useful. CONCLUSIONS: Penile incurvation improved in 77% of the patients. Fibrous plaques were reduced more than 0.5 cm on ultrasound (average 0.64 cm). SN - 0004-0614 UR - https://wwww.unboundmedicine.com/medline/citation/14595885/[Propoleum_and_Peyronie's_disease]_ L2 - http://www.aeurologia.com/articulo_prod.php?id_art=2655425152072 DB - PRIME DP - Unbound Medicine ER -